Alessia Pellerino

29PUBLICATIONS
130CO-AUTHORS
Predictive and prognostic markersMining, energy and natural resources lawCancer therapy (excl. chemotherapy and radiation therapy)Comparative and cross-cultural educationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 30, 2026
Gliomas with pleomorphic and pseudopapillary features (GPAP) are circumscribed tumors with targetable mutations, prolonged survival, and frequent tumor predisposition.

|Jun 16, 2026
Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 Tumors.

|Dec 01, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Sep 16, 2025
Early seizure freedom with [18F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report.

Roberta Rudà, Francesco Bruno, Alessia Pellerino

|Aug 12, 2025
STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcome.

Alessia Pellerino, Neibla Priego, Luca Bertero

|Mar 18, 2025
Education paths in neuro-oncology: combining technical skills with multidisciplinary care. A survey from the AINO (Italian Association for Neuro-Oncology) Youngster Committee.

Rina Di Bonaventura, Denis Aiudi, Silvia Chiesa

Pageof 5

Frequent Collaborators

16 joint publications

Riccardo Soffietti

11 joint publications

Luca Bertero

9 joint publications

Roberta Rudà

5 joint publications

Francesco Bruno